Antibiotic Resistance Market, Global Outlook and Forecast 2022-2028
Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
This report contains market size and forecasts of Antibiotic Resistance in global, including the following market information:
Global Antibiotic Resistance Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antibiotic Resistance Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Antibiotic Resistance companies in 2021 (%)
The global Antibiotic Resistance market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibiotic Resistance include Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience and Phage Technologies S.A, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibiotic Resistance manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibiotic Resistance Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antibiotic Resistance Market Segment Percentages, by Type, 2021 (%)
Global Antibiotic Resistance Market Segment Percentages, by Application, 2021 (%)
Global Antibiotic Resistance Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Antibiotic Resistance revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antibiotic Resistance revenues share in global market, 2021 (%)
Key companies Antibiotic Resistance sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Antibiotic Resistance sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Antibiotic Resistance in global, including the following market information:
Global Antibiotic Resistance Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antibiotic Resistance Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Antibiotic Resistance companies in 2021 (%)
The global Antibiotic Resistance market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
By Disease Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibiotic Resistance include Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience and Phage Technologies S.A, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibiotic Resistance manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibiotic Resistance Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Antibiotic Resistance Market Segment Percentages, by Type, 2021 (%)
- By Disease
- By Pathogen
Global Antibiotic Resistance Market Segment Percentages, by Application, 2021 (%)
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Cephalosporins
- Combination therapies
- Other
Global Antibiotic Resistance Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Antibiotic Resistance revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antibiotic Resistance revenues share in global market, 2021 (%)
Key companies Antibiotic Resistance sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Antibiotic Resistance sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Allergan
- AmpliPhi Biosciences
- BioVersys GmbH
- Macrolide Pharmaceuticals
- Melinta Therapeutics
- Merck
- Nabriva Therapeutics
- Nemesis Bioscience
- Phage Technologies S.A
- Tetraphase Pharmaceuticals
- The Medicines Company
- TPfizer
- Westway Health
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Antibiotic Resistance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibiotic Resistance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIBIOTIC RESISTANCE OVERALL MARKET SIZE
2.1 Global Antibiotic Resistance Market Size: 2021 VS 2028
2.2 Global Antibiotic Resistance Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibiotic Resistance Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antibiotic Resistance Players in Global Market
3.2 Top Global Antibiotic Resistance Companies Ranked by Revenue
3.3 Global Antibiotic Resistance Revenue by Companies
3.4 Global Antibiotic Resistance Sales by Companies
3.5 Global Antibiotic Resistance Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibiotic Resistance Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibiotic Resistance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibiotic Resistance Players in Global Market
3.8.1 List of Global Tier 1 Antibiotic Resistance Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibiotic Resistance Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antibiotic Resistance Market Size Markets, 2021 & 2028
By Disease
By Pathogen
4.2 By Type - Global Antibiotic Resistance Revenue & Forecasts
4.2.1 By Type - Global Antibiotic Resistance Revenue, 2017-2022
4.2.2 By Type - Global Antibiotic Resistance Revenue, 2023-2028
4.2.3 By Type - Global Antibiotic Resistance Revenue Market Share, 2017-2028
4.3 By Type - Global Antibiotic Resistance Sales & Forecasts
4.3.1 By Type - Global Antibiotic Resistance Sales, 2017-2022
4.3.2 By Type - Global Antibiotic Resistance Sales, 2023-2028
4.3.3 By Type - Global Antibiotic Resistance Sales Market Share, 2017-2028
4.4 By Type - Global Antibiotic Resistance Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antibiotic Resistance Market Size, 2021 & 2028
5.1.2 Oxazolidinones
5.1.3 Lipoglycopeptides
5.1.4 Tetracyclines
5.1.5 Cephalosporins
5.1.6 Combination therapies
5.1.7 Other
5.2 By Application - Global Antibiotic Resistance Revenue & Forecasts
5.2.1 By Application - Global Antibiotic Resistance Revenue, 2017-2022
5.2.2 By Application - Global Antibiotic Resistance Revenue, 2023-2028
5.2.3 By Application - Global Antibiotic Resistance Revenue Market Share, 2017-2028
5.3 By Application - Global Antibiotic Resistance Sales & Forecasts
5.3.1 By Application - Global Antibiotic Resistance Sales, 2017-2022
5.3.2 By Application - Global Antibiotic Resistance Sales, 2023-2028
5.3.3 By Application - Global Antibiotic Resistance Sales Market Share, 2017-2028
5.4 By Application - Global Antibiotic Resistance Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antibiotic Resistance Market Size, 2021 & 2028
6.2 By Region - Global Antibiotic Resistance Revenue & Forecasts
6.2.1 By Region - Global Antibiotic Resistance Revenue, 2017-2022
6.2.2 By Region - Global Antibiotic Resistance Revenue, 2023-2028
6.2.3 By Region - Global Antibiotic Resistance Revenue Market Share, 2017-2028
6.3 By Region - Global Antibiotic Resistance Sales & Forecasts
6.3.1 By Region - Global Antibiotic Resistance Sales, 2017-2022
6.3.2 By Region - Global Antibiotic Resistance Sales, 2023-2028
6.3.3 By Region - Global Antibiotic Resistance Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antibiotic Resistance Revenue, 2017-2028
6.4.2 By Country - North America Antibiotic Resistance Sales, 2017-2028
6.4.3 US Antibiotic Resistance Market Size, 2017-2028
6.4.4 Canada Antibiotic Resistance Market Size, 2017-2028
6.4.5 Mexico Antibiotic Resistance Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antibiotic Resistance Revenue, 2017-2028
6.5.2 By Country - Europe Antibiotic Resistance Sales, 2017-2028
6.5.3 Germany Antibiotic Resistance Market Size, 2017-2028
6.5.4 France Antibiotic Resistance Market Size, 2017-2028
6.5.5 U.K. Antibiotic Resistance Market Size, 2017-2028
6.5.6 Italy Antibiotic Resistance Market Size, 2017-2028
6.5.7 Russia Antibiotic Resistance Market Size, 2017-2028
6.5.8 Nordic Countries Antibiotic Resistance Market Size, 2017-2028
6.5.9 Benelux Antibiotic Resistance Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antibiotic Resistance Revenue, 2017-2028
6.6.2 By Region - Asia Antibiotic Resistance Sales, 2017-2028
6.6.3 China Antibiotic Resistance Market Size, 2017-2028
6.6.4 Japan Antibiotic Resistance Market Size, 2017-2028
6.6.5 South Korea Antibiotic Resistance Market Size, 2017-2028
6.6.6 Southeast Asia Antibiotic Resistance Market Size, 2017-2028
6.6.7 India Antibiotic Resistance Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antibiotic Resistance Revenue, 2017-2028
6.7.2 By Country - South America Antibiotic Resistance Sales, 2017-2028
6.7.3 Brazil Antibiotic Resistance Market Size, 2017-2028
6.7.4 Argentina Antibiotic Resistance Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibiotic Resistance Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antibiotic Resistance Sales, 2017-2028
6.8.3 Turkey Antibiotic Resistance Market Size, 2017-2028
6.8.4 Israel Antibiotic Resistance Market Size, 2017-2028
6.8.5 Saudi Arabia Antibiotic Resistance Market Size, 2017-2028
6.8.6 UAE Antibiotic Resistance Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Antibiotic Resistance Major Product Offerings
7.1.4 Allergan Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.1.5 Allergan Key News
7.2 AmpliPhi Biosciences
7.2.1 AmpliPhi Biosciences Corporate Summary
7.2.2 AmpliPhi Biosciences Business Overview
7.2.3 AmpliPhi Biosciences Antibiotic Resistance Major Product Offerings
7.2.4 AmpliPhi Biosciences Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.2.5 AmpliPhi Biosciences Key News
7.3 BioVersys GmbH
7.3.1 BioVersys GmbH Corporate Summary
7.3.2 BioVersys GmbH Business Overview
7.3.3 BioVersys GmbH Antibiotic Resistance Major Product Offerings
7.3.4 BioVersys GmbH Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.3.5 BioVersys GmbH Key News
7.4 Macrolide Pharmaceuticals
7.4.1 Macrolide Pharmaceuticals Corporate Summary
7.4.2 Macrolide Pharmaceuticals Business Overview
7.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Major Product Offerings
7.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.4.5 Macrolide Pharmaceuticals Key News
7.5 Melinta Therapeutics
7.5.1 Melinta Therapeutics Corporate Summary
7.5.2 Melinta Therapeutics Business Overview
7.5.3 Melinta Therapeutics Antibiotic Resistance Major Product Offerings
7.5.4 Melinta Therapeutics Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.5.5 Melinta Therapeutics Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Antibiotic Resistance Major Product Offerings
7.6.4 Merck Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Nabriva Therapeutics
7.7.1 Nabriva Therapeutics Corporate Summary
7.7.2 Nabriva Therapeutics Business Overview
7.7.3 Nabriva Therapeutics Antibiotic Resistance Major Product Offerings
7.7.4 Nabriva Therapeutics Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.7.5 Nabriva Therapeutics Key News
7.8 Nemesis Bioscience
7.8.1 Nemesis Bioscience Corporate Summary
7.8.2 Nemesis Bioscience Business Overview
7.8.3 Nemesis Bioscience Antibiotic Resistance Major Product Offerings
7.8.4 Nemesis Bioscience Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.8.5 Nemesis Bioscience Key News
7.9 Phage Technologies S.A
7.9.1 Phage Technologies S.A Corporate Summary
7.9.2 Phage Technologies S.A Business Overview
7.9.3 Phage Technologies S.A Antibiotic Resistance Major Product Offerings
7.9.4 Phage Technologies S.A Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.9.5 Phage Technologies S.A Key News
7.10 Tetraphase Pharmaceuticals
7.10.1 Tetraphase Pharmaceuticals Corporate Summary
7.10.2 Tetraphase Pharmaceuticals Business Overview
7.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Major Product Offerings
7.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.10.5 Tetraphase Pharmaceuticals Key News
7.11 The Medicines Company
7.11.1 The Medicines Company Corporate Summary
7.11.2 The Medicines Company Antibiotic Resistance Business Overview
7.11.3 The Medicines Company Antibiotic Resistance Major Product Offerings
7.11.4 The Medicines Company Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.11.5 The Medicines Company Key News
7.12 TPfizer
7.12.1 TPfizer Corporate Summary
7.12.2 TPfizer Antibiotic Resistance Business Overview
7.12.3 TPfizer Antibiotic Resistance Major Product Offerings
7.12.4 TPfizer Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.12.5 TPfizer Key News
7.13 Westway Health
7.13.1 Westway Health Corporate Summary
7.13.2 Westway Health Antibiotic Resistance Business Overview
7.13.3 Westway Health Antibiotic Resistance Major Product Offerings
7.13.4 Westway Health Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.13.5 Westway Health Key News
8 GLOBAL ANTIBIOTIC RESISTANCE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antibiotic Resistance Production Capacity, 2017-2028
8.2 Antibiotic Resistance Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibiotic Resistance Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIBIOTIC RESISTANCE SUPPLY CHAIN ANALYSIS
10.1 Antibiotic Resistance Industry Value Chain
10.2 Antibiotic Resistance Upstream Market
10.3 Antibiotic Resistance Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibiotic Resistance Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Antibiotic Resistance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antibiotic Resistance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ANTIBIOTIC RESISTANCE OVERALL MARKET SIZE
2.1 Global Antibiotic Resistance Market Size: 2021 VS 2028
2.2 Global Antibiotic Resistance Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibiotic Resistance Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Antibiotic Resistance Players in Global Market
3.2 Top Global Antibiotic Resistance Companies Ranked by Revenue
3.3 Global Antibiotic Resistance Revenue by Companies
3.4 Global Antibiotic Resistance Sales by Companies
3.5 Global Antibiotic Resistance Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibiotic Resistance Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibiotic Resistance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibiotic Resistance Players in Global Market
3.8.1 List of Global Tier 1 Antibiotic Resistance Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibiotic Resistance Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Antibiotic Resistance Market Size Markets, 2021 & 2028
By Disease
By Pathogen
4.2 By Type - Global Antibiotic Resistance Revenue & Forecasts
4.2.1 By Type - Global Antibiotic Resistance Revenue, 2017-2022
4.2.2 By Type - Global Antibiotic Resistance Revenue, 2023-2028
4.2.3 By Type - Global Antibiotic Resistance Revenue Market Share, 2017-2028
4.3 By Type - Global Antibiotic Resistance Sales & Forecasts
4.3.1 By Type - Global Antibiotic Resistance Sales, 2017-2022
4.3.2 By Type - Global Antibiotic Resistance Sales, 2023-2028
4.3.3 By Type - Global Antibiotic Resistance Sales Market Share, 2017-2028
4.4 By Type - Global Antibiotic Resistance Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Antibiotic Resistance Market Size, 2021 & 2028
5.1.2 Oxazolidinones
5.1.3 Lipoglycopeptides
5.1.4 Tetracyclines
5.1.5 Cephalosporins
5.1.6 Combination therapies
5.1.7 Other
5.2 By Application - Global Antibiotic Resistance Revenue & Forecasts
5.2.1 By Application - Global Antibiotic Resistance Revenue, 2017-2022
5.2.2 By Application - Global Antibiotic Resistance Revenue, 2023-2028
5.2.3 By Application - Global Antibiotic Resistance Revenue Market Share, 2017-2028
5.3 By Application - Global Antibiotic Resistance Sales & Forecasts
5.3.1 By Application - Global Antibiotic Resistance Sales, 2017-2022
5.3.2 By Application - Global Antibiotic Resistance Sales, 2023-2028
5.3.3 By Application - Global Antibiotic Resistance Sales Market Share, 2017-2028
5.4 By Application - Global Antibiotic Resistance Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Antibiotic Resistance Market Size, 2021 & 2028
6.2 By Region - Global Antibiotic Resistance Revenue & Forecasts
6.2.1 By Region - Global Antibiotic Resistance Revenue, 2017-2022
6.2.2 By Region - Global Antibiotic Resistance Revenue, 2023-2028
6.2.3 By Region - Global Antibiotic Resistance Revenue Market Share, 2017-2028
6.3 By Region - Global Antibiotic Resistance Sales & Forecasts
6.3.1 By Region - Global Antibiotic Resistance Sales, 2017-2022
6.3.2 By Region - Global Antibiotic Resistance Sales, 2023-2028
6.3.3 By Region - Global Antibiotic Resistance Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antibiotic Resistance Revenue, 2017-2028
6.4.2 By Country - North America Antibiotic Resistance Sales, 2017-2028
6.4.3 US Antibiotic Resistance Market Size, 2017-2028
6.4.4 Canada Antibiotic Resistance Market Size, 2017-2028
6.4.5 Mexico Antibiotic Resistance Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antibiotic Resistance Revenue, 2017-2028
6.5.2 By Country - Europe Antibiotic Resistance Sales, 2017-2028
6.5.3 Germany Antibiotic Resistance Market Size, 2017-2028
6.5.4 France Antibiotic Resistance Market Size, 2017-2028
6.5.5 U.K. Antibiotic Resistance Market Size, 2017-2028
6.5.6 Italy Antibiotic Resistance Market Size, 2017-2028
6.5.7 Russia Antibiotic Resistance Market Size, 2017-2028
6.5.8 Nordic Countries Antibiotic Resistance Market Size, 2017-2028
6.5.9 Benelux Antibiotic Resistance Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antibiotic Resistance Revenue, 2017-2028
6.6.2 By Region - Asia Antibiotic Resistance Sales, 2017-2028
6.6.3 China Antibiotic Resistance Market Size, 2017-2028
6.6.4 Japan Antibiotic Resistance Market Size, 2017-2028
6.6.5 South Korea Antibiotic Resistance Market Size, 2017-2028
6.6.6 Southeast Asia Antibiotic Resistance Market Size, 2017-2028
6.6.7 India Antibiotic Resistance Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antibiotic Resistance Revenue, 2017-2028
6.7.2 By Country - South America Antibiotic Resistance Sales, 2017-2028
6.7.3 Brazil Antibiotic Resistance Market Size, 2017-2028
6.7.4 Argentina Antibiotic Resistance Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibiotic Resistance Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antibiotic Resistance Sales, 2017-2028
6.8.3 Turkey Antibiotic Resistance Market Size, 2017-2028
6.8.4 Israel Antibiotic Resistance Market Size, 2017-2028
6.8.5 Saudi Arabia Antibiotic Resistance Market Size, 2017-2028
6.8.6 UAE Antibiotic Resistance Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Antibiotic Resistance Major Product Offerings
7.1.4 Allergan Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.1.5 Allergan Key News
7.2 AmpliPhi Biosciences
7.2.1 AmpliPhi Biosciences Corporate Summary
7.2.2 AmpliPhi Biosciences Business Overview
7.2.3 AmpliPhi Biosciences Antibiotic Resistance Major Product Offerings
7.2.4 AmpliPhi Biosciences Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.2.5 AmpliPhi Biosciences Key News
7.3 BioVersys GmbH
7.3.1 BioVersys GmbH Corporate Summary
7.3.2 BioVersys GmbH Business Overview
7.3.3 BioVersys GmbH Antibiotic Resistance Major Product Offerings
7.3.4 BioVersys GmbH Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.3.5 BioVersys GmbH Key News
7.4 Macrolide Pharmaceuticals
7.4.1 Macrolide Pharmaceuticals Corporate Summary
7.4.2 Macrolide Pharmaceuticals Business Overview
7.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Major Product Offerings
7.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.4.5 Macrolide Pharmaceuticals Key News
7.5 Melinta Therapeutics
7.5.1 Melinta Therapeutics Corporate Summary
7.5.2 Melinta Therapeutics Business Overview
7.5.3 Melinta Therapeutics Antibiotic Resistance Major Product Offerings
7.5.4 Melinta Therapeutics Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.5.5 Melinta Therapeutics Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Antibiotic Resistance Major Product Offerings
7.6.4 Merck Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Nabriva Therapeutics
7.7.1 Nabriva Therapeutics Corporate Summary
7.7.2 Nabriva Therapeutics Business Overview
7.7.3 Nabriva Therapeutics Antibiotic Resistance Major Product Offerings
7.7.4 Nabriva Therapeutics Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.7.5 Nabriva Therapeutics Key News
7.8 Nemesis Bioscience
7.8.1 Nemesis Bioscience Corporate Summary
7.8.2 Nemesis Bioscience Business Overview
7.8.3 Nemesis Bioscience Antibiotic Resistance Major Product Offerings
7.8.4 Nemesis Bioscience Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.8.5 Nemesis Bioscience Key News
7.9 Phage Technologies S.A
7.9.1 Phage Technologies S.A Corporate Summary
7.9.2 Phage Technologies S.A Business Overview
7.9.3 Phage Technologies S.A Antibiotic Resistance Major Product Offerings
7.9.4 Phage Technologies S.A Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.9.5 Phage Technologies S.A Key News
7.10 Tetraphase Pharmaceuticals
7.10.1 Tetraphase Pharmaceuticals Corporate Summary
7.10.2 Tetraphase Pharmaceuticals Business Overview
7.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Major Product Offerings
7.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.10.5 Tetraphase Pharmaceuticals Key News
7.11 The Medicines Company
7.11.1 The Medicines Company Corporate Summary
7.11.2 The Medicines Company Antibiotic Resistance Business Overview
7.11.3 The Medicines Company Antibiotic Resistance Major Product Offerings
7.11.4 The Medicines Company Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.11.5 The Medicines Company Key News
7.12 TPfizer
7.12.1 TPfizer Corporate Summary
7.12.2 TPfizer Antibiotic Resistance Business Overview
7.12.3 TPfizer Antibiotic Resistance Major Product Offerings
7.12.4 TPfizer Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.12.5 TPfizer Key News
7.13 Westway Health
7.13.1 Westway Health Corporate Summary
7.13.2 Westway Health Antibiotic Resistance Business Overview
7.13.3 Westway Health Antibiotic Resistance Major Product Offerings
7.13.4 Westway Health Antibiotic Resistance Sales and Revenue in Global (2017-2022)
7.13.5 Westway Health Key News
8 GLOBAL ANTIBIOTIC RESISTANCE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Antibiotic Resistance Production Capacity, 2017-2028
8.2 Antibiotic Resistance Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibiotic Resistance Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ANTIBIOTIC RESISTANCE SUPPLY CHAIN ANALYSIS
10.1 Antibiotic Resistance Industry Value Chain
10.2 Antibiotic Resistance Upstream Market
10.3 Antibiotic Resistance Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibiotic Resistance Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Antibiotic Resistance in Global Market
Table 2. Top Antibiotic Resistance Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antibiotic Resistance Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antibiotic Resistance Revenue Share by Companies, 2017-2022
Table 5. Global Antibiotic Resistance Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Antibiotic Resistance Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antibiotic Resistance Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Antibiotic Resistance Product Type
Table 9. List of Global Tier 1 Antibiotic Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibiotic Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibiotic Resistance Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antibiotic Resistance Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antibiotic Resistance Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antibiotic Resistance Sales (K Pcs), 2017-2022
Table 15. By Type - Global Antibiotic Resistance Sales (K Pcs), 2023-2028
Table 16. By Application – Global Antibiotic Resistance Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antibiotic Resistance Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antibiotic Resistance Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antibiotic Resistance Sales (K Pcs), 2017-2022
Table 20. By Application - Global Antibiotic Resistance Sales (K Pcs), 2023-2028
Table 21. By Region – Global Antibiotic Resistance Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antibiotic Resistance Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antibiotic Resistance Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antibiotic Resistance Sales (K Pcs), 2017-2022
Table 25. By Region - Global Antibiotic Resistance Sales (K Pcs), 2023-2028
Table 26. By Country - North America Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 46. Allergan Corporate Summary
Table 47. Allergan Antibiotic Resistance Product Offerings
Table 48. Allergan Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. AmpliPhi Biosciences Corporate Summary
Table 50. AmpliPhi Biosciences Antibiotic Resistance Product Offerings
Table 51. AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. BioVersys GmbH Corporate Summary
Table 53. BioVersys GmbH Antibiotic Resistance Product Offerings
Table 54. BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Macrolide Pharmaceuticals Corporate Summary
Table 56. Macrolide Pharmaceuticals Antibiotic Resistance Product Offerings
Table 57. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Melinta Therapeutics Corporate Summary
Table 59. Melinta Therapeutics Antibiotic Resistance Product Offerings
Table 60. Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Antibiotic Resistance Product Offerings
Table 63. Merck Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Nabriva Therapeutics Corporate Summary
Table 65. Nabriva Therapeutics Antibiotic Resistance Product Offerings
Table 66. Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Nemesis Bioscience Corporate Summary
Table 68. Nemesis Bioscience Antibiotic Resistance Product Offerings
Table 69. Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Phage Technologies S.A Corporate Summary
Table 71. Phage Technologies S.A Antibiotic Resistance Product Offerings
Table 72. Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Tetraphase Pharmaceuticals Corporate Summary
Table 74. Tetraphase Pharmaceuticals Antibiotic Resistance Product Offerings
Table 75. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. The Medicines Company Corporate Summary
Table 77. The Medicines Company Antibiotic Resistance Product Offerings
Table 78. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. TPfizer Corporate Summary
Table 80. TPfizer Antibiotic Resistance Product Offerings
Table 81. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Westway Health Corporate Summary
Table 83. Westway Health Antibiotic Resistance Product Offerings
Table 84. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Antibiotic Resistance Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 86. Global Antibiotic Resistance Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Antibiotic Resistance Production by Region, 2017-2022 (K Pcs)
Table 88. Global Antibiotic Resistance Production by Region, 2023-2028 (K Pcs)
Table 89. Antibiotic Resistance Market Opportunities & Trends in Global Market
Table 90. Antibiotic Resistance Market Drivers in Global Market
Table 91. Antibiotic Resistance Market Restraints in Global Market
Table 92. Antibiotic Resistance Raw Materials
Table 93. Antibiotic Resistance Raw Materials Suppliers in Global Market
Table 94. Typical Antibiotic Resistance Downstream
Table 95. Antibiotic Resistance Downstream Clients in Global Market
Table 96. Antibiotic Resistance Distributors and Sales Agents in Global Market
Table 1. Key Players of Antibiotic Resistance in Global Market
Table 2. Top Antibiotic Resistance Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antibiotic Resistance Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antibiotic Resistance Revenue Share by Companies, 2017-2022
Table 5. Global Antibiotic Resistance Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Antibiotic Resistance Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antibiotic Resistance Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Antibiotic Resistance Product Type
Table 9. List of Global Tier 1 Antibiotic Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibiotic Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibiotic Resistance Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antibiotic Resistance Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antibiotic Resistance Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antibiotic Resistance Sales (K Pcs), 2017-2022
Table 15. By Type - Global Antibiotic Resistance Sales (K Pcs), 2023-2028
Table 16. By Application – Global Antibiotic Resistance Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Antibiotic Resistance Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Antibiotic Resistance Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Antibiotic Resistance Sales (K Pcs), 2017-2022
Table 20. By Application - Global Antibiotic Resistance Sales (K Pcs), 2023-2028
Table 21. By Region – Global Antibiotic Resistance Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antibiotic Resistance Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antibiotic Resistance Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antibiotic Resistance Sales (K Pcs), 2017-2022
Table 25. By Region - Global Antibiotic Resistance Sales (K Pcs), 2023-2028
Table 26. By Country - North America Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Antibiotic Resistance Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antibiotic Resistance Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antibiotic Resistance Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Antibiotic Resistance Sales, (K Pcs), 2023-2028
Table 46. Allergan Corporate Summary
Table 47. Allergan Antibiotic Resistance Product Offerings
Table 48. Allergan Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. AmpliPhi Biosciences Corporate Summary
Table 50. AmpliPhi Biosciences Antibiotic Resistance Product Offerings
Table 51. AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. BioVersys GmbH Corporate Summary
Table 53. BioVersys GmbH Antibiotic Resistance Product Offerings
Table 54. BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Macrolide Pharmaceuticals Corporate Summary
Table 56. Macrolide Pharmaceuticals Antibiotic Resistance Product Offerings
Table 57. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Melinta Therapeutics Corporate Summary
Table 59. Melinta Therapeutics Antibiotic Resistance Product Offerings
Table 60. Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Antibiotic Resistance Product Offerings
Table 63. Merck Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Nabriva Therapeutics Corporate Summary
Table 65. Nabriva Therapeutics Antibiotic Resistance Product Offerings
Table 66. Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Nemesis Bioscience Corporate Summary
Table 68. Nemesis Bioscience Antibiotic Resistance Product Offerings
Table 69. Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Phage Technologies S.A Corporate Summary
Table 71. Phage Technologies S.A Antibiotic Resistance Product Offerings
Table 72. Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Tetraphase Pharmaceuticals Corporate Summary
Table 74. Tetraphase Pharmaceuticals Antibiotic Resistance Product Offerings
Table 75. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. The Medicines Company Corporate Summary
Table 77. The Medicines Company Antibiotic Resistance Product Offerings
Table 78. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. TPfizer Corporate Summary
Table 80. TPfizer Antibiotic Resistance Product Offerings
Table 81. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Westway Health Corporate Summary
Table 83. Westway Health Antibiotic Resistance Product Offerings
Table 84. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Antibiotic Resistance Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 86. Global Antibiotic Resistance Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Antibiotic Resistance Production by Region, 2017-2022 (K Pcs)
Table 88. Global Antibiotic Resistance Production by Region, 2023-2028 (K Pcs)
Table 89. Antibiotic Resistance Market Opportunities & Trends in Global Market
Table 90. Antibiotic Resistance Market Drivers in Global Market
Table 91. Antibiotic Resistance Market Restraints in Global Market
Table 92. Antibiotic Resistance Raw Materials
Table 93. Antibiotic Resistance Raw Materials Suppliers in Global Market
Table 94. Typical Antibiotic Resistance Downstream
Table 95. Antibiotic Resistance Downstream Clients in Global Market
Table 96. Antibiotic Resistance Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Antibiotic Resistance Segment by Type
Figure 2. Antibiotic Resistance Segment by Application
Figure 3. Global Antibiotic Resistance Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibiotic Resistance Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibiotic Resistance Revenue, 2017-2028 (US$, Mn)
Figure 7. Antibiotic Resistance Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Antibiotic Resistance Revenue in 2021
Figure 9. By Type - Global Antibiotic Resistance Sales Market Share, 2017-2028
Figure 10. By Type - Global Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antibiotic Resistance Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Antibiotic Resistance Sales Market Share, 2017-2028
Figure 13. By Application - Global Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antibiotic Resistance Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Antibiotic Resistance Sales Market Share, 2017-2028
Figure 16. By Region - Global Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antibiotic Resistance Sales Market Share, 2017-2028
Figure 19. US Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antibiotic Resistance Sales Market Share, 2017-2028
Figure 24. Germany Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 25. France Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antibiotic Resistance Sales Market Share, 2017-2028
Figure 33. China Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 37. India Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antibiotic Resistance Sales Market Share, 2017-2028
Figure 40. Brazil Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antibiotic Resistance Sales Market Share, 2017-2028
Figure 44. Turkey Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antibiotic Resistance Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Antibiotic Resistance by Region, 2021 VS 2028
Figure 50. Antibiotic Resistance Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Antibiotic Resistance Segment by Type
Figure 2. Antibiotic Resistance Segment by Application
Figure 3. Global Antibiotic Resistance Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibiotic Resistance Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibiotic Resistance Revenue, 2017-2028 (US$, Mn)
Figure 7. Antibiotic Resistance Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Antibiotic Resistance Revenue in 2021
Figure 9. By Type - Global Antibiotic Resistance Sales Market Share, 2017-2028
Figure 10. By Type - Global Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antibiotic Resistance Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Antibiotic Resistance Sales Market Share, 2017-2028
Figure 13. By Application - Global Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 14. By Application - Global Antibiotic Resistance Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Antibiotic Resistance Sales Market Share, 2017-2028
Figure 16. By Region - Global Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antibiotic Resistance Sales Market Share, 2017-2028
Figure 19. US Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antibiotic Resistance Sales Market Share, 2017-2028
Figure 24. Germany Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 25. France Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antibiotic Resistance Sales Market Share, 2017-2028
Figure 33. China Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 37. India Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antibiotic Resistance Sales Market Share, 2017-2028
Figure 40. Brazil Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antibiotic Resistance Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antibiotic Resistance Sales Market Share, 2017-2028
Figure 44. Turkey Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antibiotic Resistance Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antibiotic Resistance Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Antibiotic Resistance by Region, 2021 VS 2028
Figure 50. Antibiotic Resistance Industry Value Chain
Figure 51. Marketing Channels
